Search

everythinglearnresearchcommunity

for

Search:↓

Women over forty can maintain skin and hair health with lifestyle and dietary changes.

PCOS increases the risk of heart disease and type 2 diabetes in women.

Low-level light therapy is FDA-approved for male pattern hair loss, increases hair count and strength, and is considered safe for use.

Injections improve hair growth, density, and thickness in women safely.

The over-the-counter supplement DHEA could make COVID-19 worse, especially in diabetics and people with G6PD deficiency.

Isotretinoin can cause serious birth defects and needs careful use, especially in pregnant women.

Medications for glucose metabolism and weight control, combined therapy options, and herbal medicines may help regulate menstrual cycle in adolescents with PCOS.

Combining platelet-rich plasma with other treatments may improve hair growth in people with hair loss, but more research is needed.

AA–TF#15 significantly promotes hair regrowth and could be an effective treatment for androgenic alopecia.

Female pattern hair loss has multiple causes and treatments, with new therapies showing promise.

The compounds tested could potentially treat hair loss and alopecia.

Frontal fibrosing alopecia is a poorly understood condition with increasing cases and unclear treatment effectiveness.

The hair growth solution reduced hair loss and increased hair thickness in a small group of patients.

The 2940-nm Er: YAG laser combined with medication is a safe and better treatment for male hair loss than medication alone.

The treatment combining platelet-rich plasma and a non-cross-linked hyaluronic acid compound significantly improved hair density and reduced bald areas in women with androgenetic alopecia, and it's safe with only mild side effects.

More personalized and effective treatments for androgenetic alopecia are needed.

Teak leaf extract contains compounds that could help treat hair loss.

Non-hormonal treatments should be used first for sexual dysfunction in postmenopausal breast cancer patients on aromatase inhibitors, with hormones as a second option.

Minoxidil can reduce functions related to androgen receptors.

Sex hormones like estrogen and testosterone may affect COVID-19 severity differently in men and women, potentially influencing prevention and treatment strategies.

Polycystic ovary syndrome increases the risk of diabetes, heart disease, and endometrial cancer, and requires early treatment to manage these risks.

The LncRNA AC010789.1 slows down hair loss by promoting hair follicle growth and interacting with miR-21 and the Wnt/β-catenin pathway.

Changes in gut bacteria can contribute to the development of Polycystic Ovary Syndrome (PCOS), affecting metabolism, immunity, and causing inflammation. Treatments may involve adjusting these factors.

Using adipose-derived stem cell media with minoxidil may help regrow hair in men with hair loss.

Surgery can be a safe and effective option for infertile women with PCOS who don't respond to medication and want to get pregnant.

Women with Polycystic Ovary Syndrome (PCOS) have a higher risk of developing type 2 diabetes due to insulin resistance.

Hormone treatment for transsexual individuals is effective but carries risks like thromboembolic events and mood changes, with most side effects being minor and reversible.

Uterine transplants for transgender women are feasible but need more research.

Minoxidil and finasteride are the best for non-scarring hair loss; more research is needed for scarring hair loss treatments.

New treatments like nanotechnology show promise in improving skin cancer therapy.